BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37961340)

  • 1. Tumor- and Nerve-Derived Axon Guidance Molecule Promotes Pancreatic Ductal Adenocarcinoma Progression and Metastasis through Macrophage Reprogramming.
    Thielman NRJ; Funes V; Davuluri S; Ibanez HE; Sun WC; Fu J; Li K; Muth S; Pan X; Fujiwara K; Thomas D; Henderson M; Teh SS; Zhu Q; Thompson E; Jaffee EM; Kolodkin A; Meng F; Zheng L
    bioRxiv; 2023 Oct; ():. PubMed ID: 37961340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice.
    Jurcak NR; Rucki AA; Muth S; Thompson E; Sharma R; Ding D; Zhu Q; Eshleman JR; Anders RA; Jaffee EM; Fujiwara K; Zheng L
    Gastroenterology; 2019 Sep; 157(3):838-850.e6. PubMed ID: 31163177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer.
    Foley K; Rucki AA; Xiao Q; Zhou D; Leubner A; Mo G; Kleponis J; Wu AA; Sharma R; Jiang Q; Anders RA; Iacobuzio-Donahue CA; Hajjar KA; Maitra A; Jaffee EM; Zheng L
    Sci Signal; 2015 Aug; 8(388):ra77. PubMed ID: 26243191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism.
    Zhang M; Pan X; Fujiwara K; Jurcak N; Muth S; Zhou J; Xiao Q; Li A; Che X; Li Z; Zheng L
    Signal Transduct Target Ther; 2021 Oct; 6(1):366. PubMed ID: 34711804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.
    Aghajanian H; Choi C; Ho VC; Gupta M; Singh MK; Epstein JA
    J Biol Chem; 2014 Jun; 289(26):17971-9. PubMed ID: 24825896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras.
    Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells.
    Gitto SB; Beardsley JM; Nakkina SP; Oyer JL; Cline KA; Litherland SA; Copik AJ; Khaled AS; Fanaian N; Arnoletti JP; Altomare DA
    Cell Commun Signal; 2020 Jun; 18(1):95. PubMed ID: 32552827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.
    Ocal O; Pashkov V; Kollipara RK; Zolghadri Y; Cruz VH; Hale MA; Heath BR; Artyukhin AB; Christie AL; Tsoulfas P; Lorens JB; Swift GH; Brekken RA; Wilkie TM
    Dis Model Mech; 2015 Oct; 8(10):1201-11. PubMed ID: 26438693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.
    Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH
    Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
    Bishehsari F; Zhang L; Barlass U; Preite NZ; Turturro S; Najor MS; Shetuni BB; Zayas JP; Mahdavinia M; Abukhdeir AM; Keshavarzian A
    Int J Cancer; 2018 Oct; 143(8):1994-2007. PubMed ID: 29756386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARF6 and AMAP1 are major targets of
    Hashimoto S; Furukawa S; Hashimoto A; Tsutaho A; Fukao A; Sakamura Y; Parajuli G; Onodera Y; Otsuka Y; Handa H; Oikawa T; Hata S; Nishikawa Y; Mizukami Y; Kodama Y; Murakami M; Fujiwara T; Hirano S; Sabe H
    Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17450-17459. PubMed ID: 31399545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma.
    Lo A; Li CP; Buza EL; Blomberg R; Govindaraju P; Avery D; Monslow J; Hsiao M; Puré E
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In Vivo.
    Li J; Qian W; Qin T; Xiao Y; Cheng L; Cao J; Chen X; Ma Q; Wu Z
    Comput Struct Biotechnol J; 2019; 17():498-506. PubMed ID: 31011408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer.
    Saxena S; Prajapati DR; Goel P; Tomar B; Hayashi Y; Atri P; Rachagani S; Grandgenett PM; Hollingsworth MA; Batra SK; Singh RK
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
    Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
    Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.